- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Opinion
Video
The AD Journey of a Construction Worker: Insights from a 38-Year-Old Caucasian Male
Author(s):
Alexandra Golant, MD, presents the case of a 38-year-old Caucasian male construction worker, diagnosed with moderate AD at age 15, and his treatment history with various interventions and physician referral considerations.
This is a video synopsis of a discussion involving Alexandra Golant, MD, Assistant Professor at the Icahn School of Medicine at Mount Sinai, focusing on a case study of a 38-year-old Caucasian male construction worker with moderate atopic dermatitis (AD) persisting on his hands and feet.
Despite prior treatments including clobetasol, urea-containing products, ceramide products, and tacrolimus, the patient's symptoms remain uncontrolled, impacting his ability to perform manual labor at work. Dr. Golant emphasizes the challenge of managing hand and foot AD, particularly in patients with moderate disease and significant impact on quality of life.
Early assessment and appropriate use of topical steroids are crucial in AD management, with Dr. Golant cautioning against daily steroid use and emphasizing the importance of understanding patients' treatment regimens to assess disease control accurately.
In cases like the construction worker, exhausted topical options necessitate referral for further evaluation and consideration of alternative topical or systemic therapies. Dr. Golant stresses the importance of tailoring treatment regimens to fit patients' lifestyles and work demands to ensure adherence and efficacy.
The case underscores the complexity of managing hand and foot AD, requiring a personalized approach and shared decision-making between patients and healthcare providers to achieve optimal outcomes. Dr. Golant's insights provide valuable guidance for clinicians in addressing the unique challenges of treating AD in individuals with occupation-related hand and foot involvement.
Video synopsis is AI-generated and reviewed by Dermatology Times® editorial staff.
